Literature DB >> 33553663

Gastric xanthoma is correlated with early gastric cancer of previously Helicobacter pylori-infected gastric mucosa.

Narihiro Shibukawa1,2, Shohei Ouchi1, Shuji Wakamatsu1, Yuhei Wakahara1, Akira Kaneko1.   

Abstract

BACKGROUND AND AIM: Successful Helicobacter pylori eradication has been shown to prevent the development of gastric cancer (GC), but clinical evidence for factors that correlate with GC of previously H. pylori-infected gastric mucosa (after eradication or natural disappearance) is limited. The purpose of our study was to identify these correlative factors.
METHODS: We retrospectively examined data from patients with previously H. pylori-infected gastric mucosa. Data from 168 patients who developed early GC and underwent endoscopic submucosal dissection (Group C) and 835 patients with no history of early GC (Group NC) were compared. We extracted data on gender; age; complications from malignant disease and diabetes mellitus; American Society of Anesthesiologists (ASA) physical status classification; and endoscopic characteristics of atrophy (open type), intestinal metaplasia, and gastric xanthoma (GX). Correlations were determined with multivariate logistic regression analysis and propensity score matching.
RESULTS: A significantly higher proportion of patients had GX in Group C than in Group NC. Age, male gender, ASA physical status classification of class III or higher, complications from malignant disease, atrophy (open type), and the presence of intestinal metaplasia and GX were identified as factors that correlated independently with GC (odds ratio = 3.65; 95% confidence interval = 2.37-5.61; P < 0.0001). Propensity score matching demonstrated that the prevalence of GC was also significantly higher in patients who were positive for GX (37.2% vs 18.3%; P < 0.0001).
CONCLUSION: GX was shown to correlate with early GC of previously H. pylori-infected gastric mucosa.
© 2020 The Authors. JGH Open: An open access journal of gastroenterology and hepatology published by Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Helicobacter pylori; eradication; gastric cancer; gastric xanthoma; natural disappearance

Year:  2020        PMID: 33553663      PMCID: PMC7857283          DOI: 10.1002/jgh3.12479

Source DB:  PubMed          Journal:  JGH Open        ISSN: 2397-9070


  19 in total

1.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

2.  Helicobacter pylori infection in gastric xanthomas: immunohistochemical analysis of 145 lesions.

Authors:  S Hori; Y Tsutsumi
Journal:  Pathol Int       Date:  1996-08       Impact factor: 2.534

3.  A close relationship between Helicobacter pylori infection and gastric xanthoma.

Authors:  H Isomoto; Y Mizuta; K Inoue; T Matsuo; T Hayakawa; M Miyazaki; K Onita; F Takeshima; K Murase; I Shimokawa; S Kohno
Journal:  Scand J Gastroenterol       Date:  1999-04       Impact factor: 2.423

4.  Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.

Authors:  Il Ju Choi; Myeong-Cherl Kook; Young-Il Kim; Soo-Jeong Cho; Jong Yeul Lee; Chan Gyoo Kim; Boram Park; Byung-Ho Nam
Journal:  N Engl J Med       Date:  2018-03-22       Impact factor: 91.245

5.  Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.

Authors:  Kazutoshi Fukase; Mototsugu Kato; Shogo Kikuchi; Kazuhiko Inoue; Naomi Uemura; Shiro Okamoto; Shuichi Terao; Kenji Amagai; Shunji Hayashi; Masahiro Asaka
Journal:  Lancet       Date:  2008-08-02       Impact factor: 79.321

6.  Investigation of the freely available easy-to-use software 'EZR' for medical statistics.

Authors:  Y Kanda
Journal:  Bone Marrow Transplant       Date:  2012-12-03       Impact factor: 5.483

7.  Is Gastric Xanthelasma an Alarming Endoscopic Marker for Advanced Atrophic Gastritis and Intestinal Metaplasia?

Authors:  Aydın Şeref Köksal; Nuretdin Suna; İsmail Hakkı Kalkan; Ahmet Tarık Eminler; Şükran Ziyşan Sakaoğulları; Nesrin Turhan; Fatih Saygılı; Ufuk Barış Kuzu; Erkin Öztaş; Erkan Parlak
Journal:  Dig Dis Sci       Date:  2016-06-01       Impact factor: 3.199

Review 8.  Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.

Authors:  Yi-Chia Lee; Tsung-Hsien Chiang; Chu-Kuang Chou; Yu-Kang Tu; Wei-Chih Liao; Ming-Shiang Wu; David Y Graham
Journal:  Gastroenterology       Date:  2016-02-02       Impact factor: 22.682

9.  Gastric Xanthoma Is a Predictive Marker for Early Gastric Cancer Detected after Helicobacter pylori Eradication.

Authors:  Narihiro Shibukawa; Shohei Ouchi; Shuji Wakamatsu; Yuhei Wakahara; Akira Kaneko
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

10.  Gastric xanthoma is a predictive marker for metachronous and synchronous gastric cancer.

Authors:  Narihiro Shibukawa; Shohei Ouchi; Shuji Wakamatsu; Yuhei Wakahara; Akira Kaneko
Journal:  World J Gastrointest Oncol       Date:  2017-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.